MODERIBA

200 Milligram Film Coated Tablet

AbbVie LimitedPA1824/006/001

Main Information

Trade NameMODERIBA
Active SubstancesRIBAVIRIN
Strength200 Milligram
Dosage FormFilm Coated Tablet
Licence HolderAbbVie Limited
Licence NumberPA1824/006/001

Group Information

ATC CodeJ05AB04 Nucleosides and nucleotides excl. reverse transcriptase inhibitors

Status

Authorised/WithdrawnAuthorised
Licence Issued07/02/2014
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.